Edition:
United Kingdom

Aravive Inc (ARAV.OQ)

ARAV.OQ on NASDAQ Stock Exchange Global Select Market

5.80USD
23 Aug 2019
Change (% chg)

-- (--)
Prev Close
$5.80
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,038
52-wk High
$11.70
52-wk Low
$3.07

About

Aravive, Inc., formerly Versartis, Inc., is a clinical-stage biotechnology company. The Company is focused on developing therapies that target survival pathways for both solid tumors, as well as hematologic malignancies. Its primary therapeutic focus is the growth arrest-specific 6 (GAS6) - AXL receptor tyrosine kinase (AXL)... (more)

Overall

Beta: 2.19
Market Cap(Mil.): $64.16
Shares Outstanding(Mil.): 11.28
Dividend: --
Yield (%): --

Financials

  ARAV.OQ Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -7.90 -- --
ROI: -97.21 7.52 12.69
ROE: -109.52 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates